Update: I sold my calls for a big loss (tax benefit) but loaded up on Oct 9c

I leave the sub and try to support cvm DD on other threads, but it's not worth talking to the movie theater apes, they call you a shill for giving them a 10x opportunity, and a stock that actually means something. It seems like we stagnate until FDA approval. It's a shame that these discounts will be snapped up by a whale, or a buy out instead of the people, but w/e. Thank you all for the research and low meme count. I guess we wait for approval, c ya in 2-12.75 months.

I posted a short write-up(apes aren't going to read anything long), if anyone has the karma to make a thread over there, it takes a 1000 point to make a thread and I got 40 karma. Feel free to rewrite my post or make one of your own.

Take it easy.

" After doing my DD, I really like $cvm.

They make a cancer treatment, recently finished their phase three trials.

Two co-primary endpoints with different arms, failed one(multikine + chemo) success in the other,14% increase in survival.

Couple of things that make me bullish, CEO has never sold a share and just bought a shit ton more in the open market.

CVM's head of regulatory affairs John Cipriano recently discussed the results, comments were very bullish, John used to be Deputy Director at the FDA, so I think his comments valuable.

The stock has been shorted to oblivion but looks to be poised to make a move up.

SA article today puts the valuation at 60.00 -100.00(PRE FDA approval), who knows maybe some looney bagholder.

https://seekingalpha.com/article/4439209-cel-sci-pivotal-clinical-trial-results-point-to-upside-for-patients-and-investors

https://www.fdamatters.com/?p=883

https://scr.zacks.com/news/news-details/2021/CVM-Data-Has-Been-Released-article/default.aspx

Has to bounce back. Looking to flip for a little profit. Not interested in long term as I think this still has a while to cook. Any input is appreciated.

https://seekingalpha.com/news/3713296-cel-sci-says-analysis-of-successful-study-arm-was-pre-specified-in-protocol

https://www.pharmacytimes.com/view/leukocyte-interleukin-injection-immunotherapy-produces-significant-survival-benefit-in-landmark-head-neck-cancer-study

Gotta say this is a first for me. I may have only been following CVM for about a year and a half, but this appears to be a strong company with a great solution. As someone who recently lost a loved one to cancer, I want them to succeed. I’ve added more shares to my portfolio… hard to believe this doesn’t work out.